News from accera, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 14, 2015, 08:00 ET

Accera Reaches 75% Enrollment in the Phase 3 NOURISH AD Study of AC-1204 for the Treatment of Alzheimer's Disease

 Accera, Inc. today announced that it has achieved 75% enrollment for its NOURISH AD Phase 3 clinical study of AC-1204 for the treatment of...

Jun 02, 2015, 08:00 ET

Accera Appoints Charles Stacey, M.D., as President and CEO

Accera, Inc. today announced the appointment of Charles Stacey, M.D., as president and chief executive officer. Dr. Stacey has an extensive...

Feb 20, 2015, 15:03 ET

Le Dr Samuel Henderson, vice-président recherche et développement chez Accera, fera un exposé à la 249e réunion nationale de l'American Chemical Society

- La présentation est intitulée « Cétose induite pour le traitement des formes légères à modérées de...

Feb 20, 2015, 15:01 ET

Dr. Samuel Henderson, der Vizepräsident für Forschung und Entwicklung von Accera, wird beim 249. American Chemical Society National Meeting anwesend sein

-- Die Präsentation trägt den Titel: Induzierte Ketose bei leichter bis mittelschwerer Alzheimer-Krankheit Accera, Inc., ein...

Feb 20, 2015, 14:58 ET

Dr. Samuel Henderson, V.P. R&D van Accera, gaat presentatie houden op de 249e nationale vergadering van American Chemical Society

- Presentatie heeft de titel: Induced ketosis in mild to moderate Alzheimer's disease Accera, Inc, een leider in de ontwikkeling van nieuwe...

Feb 20, 2015, 14:45 ET

Dr. Samuel Henderson, Accera's V.P. of Research and Development, to Present at the 249th American Chemical Society National Meeting

 Accera, Inc, a leader in the development of new therapies to treat neurological disorders, today announced that Dr. Samuel Henderson, Accera's...

Nov 11, 2013, 10:17 ET

Accera, Inc. to Moderate Symposium on Metabolic Dysregulation in Alzheimer's Disease During the 6th Annual Clinical Trials Conference on Alzheimer's Disease (CTAD)

 Accera, Inc., a privately-held, commercial-stage healthcare company focused on the discovery and development of innovative clinical...

Oct 28, 2013, 10:17 ET
Apr 09, 2013, 10:17 ET

Accera and University of Miami Announce Collaboration to Study Axona® for Cognitive Impairment in Patients with Multiple Sclerosis

 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical...

Nov 26, 2012, 10:17 ET

Accera Announces Initiation of Clinical Trial for AC-1204

 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical...

Oct 24, 2012, 10:17 ET

Accera, Inc. Expands Senior Management Team to Advance Clinical Studies & Commercialization for Axona®

 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical...

Sep 26, 2012, 10:17 ET

Accera, Inc. to Support the Alzheimer's Foundation of America's (AFA) National Memory Screening Day (NMSD)

Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications...

Sep 13, 2012, 10:17 ET

Accera, Inc. to Present at the BioPharm America™ 2012 Partnering Conference in Boston, MA

Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications...

Jul 18, 2012, 14:03 ET

Nestle Health Science takes stake in Accera, Inc. to Advance Potential of Axona®

Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications...

Mar 18, 2012, 13:00 ET

Accera, Inc. Announces Data Presentation at the Annual Meeting of the American Association for Geriatric Psychiatry (AAGP) 2012

BROOMFIELD, Colo., March 18, 2012 /PRNewswire/ -- Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery...

Jan 03, 2012, 11:27 ET

Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors

 Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative therapeutics to...

Oct 24, 2011, 10:17 ET

Accera, Inc. Donates $50,000 to the Alzheimer's Foundation of America for National Memory Screening Day

Accera, Inc., a biotech company specializing in cognitive health, announced today the company has donated $50,000 to the Alzheimer's Foundation of...

Oct 17, 2011, 10:17 ET

Genetic Profile Identified for Alzheimer's Patients Showing Heightened Response to Accera's Breakthrough Product Axona®

Accera, Inc., a biotech company specializing in cognitive health, announced today that it has identified the genetic profile of Alzheimer’s...

Oct 05, 2010, 10:17 ET

Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease

Accera, Inc., a medical research and development company delivering breakthrough therapies for serious diseases such as Alzheimer's disease (AD),...

Mar 09, 2010, 11:02 ET

New Evidence Further Validates Ketone Body Therapy as an Effective Approach in Managing Alzheimer's Disease

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that...